Losurdo G et al. |
Role of concomitant therapy for eradication: A technical note. |
2016 |
World J. Gastroenterol. |
pmid:27784977
|
Zycinska K et al. |
Antibiotic Treatment of Hospitalized Patients with Pneumonia Complicated by Clostridium Difficile Infection. |
2016 |
Adv. Exp. Med. Biol. |
pmid:27620311
|
Bax HI et al. |
Tigecycline Potentiates Clarithromycin Activity against Mycobacterium avium In Vitro. |
2016 |
Antimicrob. Agents Chemother. |
pmid:26883697
|
Zhou L et al. |
Tailored versus Triple plus Bismuth or Concomitant Therapy as Initial Helicobacter pylori Treatment: A Randomized Trial. |
2016 |
Helicobacter |
pmid:26104022
|
Couture G et al. |
[Second case of serum sickness-like reaction to claritrhomycin]. |
2016 |
Presse Med |
pmid:27542759
|
Bugli F et al. |
In vitro effect of clarithromycin and alginate lyase against helicobacter pylori biofilm. |
2016 |
Biotechnol. Prog. |
pmid:27535356
|
Shichijo S et al. |
Vonoprazan versus conventional proton pump inhibitor-based triple therapy as first-line treatment against Helicobacter pylori: A multicenter retrospective study in clinical practice. |
2016 |
J Dig Dis |
pmid:27534444
|
Lotfipour F et al. |
Study of Antimicrobial Effects of Clarithromycin Loaded PLGA Nanoparticles against Clinical Strains of Helicobacter pylori. |
2016 |
Drug Res (Stuttg) |
pmid:25919643
|
Miyaki A et al. |
An assessment of the efficacy of first-line Helicobacter pylori-eradication therapy based on clarithromycin susceptibility. |
2016 |
Minerva Gastroenterol Dietol |
pmid:27304198
|
Akram FE et al. |
A combination of silver nanoparticles and visible blue light enhances the antibacterial efficacy of ineffective antibiotics against methicillin-resistant Staphylococcus aureus (MRSA). |
2016 |
Ann. Clin. Microbiol. Antimicrob. |
pmid:27530257
|
Fallone CA et al. |
The Toronto Consensus for the Treatment of Helicobacter pylori Infection in Adults. |
2016 |
Gastroenterology |
pmid:27102658
|
Bilgilier C et al. |
Prevalence of clarithromycin-resistant Helicobacter pylori strains in gastric mucosa-associated lymphoid tissue lymphoma patients. |
2016 |
Ann. Hematol. |
pmid:27091350
|
Root AA et al. |
Evaluation of the risk of cardiovascular events with clarithromycin using both propensity score and self-controlled study designs. |
2016 |
Br J Clin Pharmacol |
pmid:27090996
|
Kazama I et al. |
Clarithromycin Dose-Dependently Stabilizes Rat Peritoneal Mast Cells. |
2016 |
Chemotherapy |
pmid:27088971
|
Guirao-Arrabal E et al. |
Clarithromycin plus linezolid as a sequential therapy for implantable-cardioverter-defibrillator infection caused by coagulase-negative staphylococci. |
2016 |
Rev Esp Quimioter |
pmid:26888341
|
Friedman ND et al. |
Increasing Experience with Primary Oral Medical Therapy for Mycobacterium ulcerans Disease in an Australian Cohort. |
2016 |
Antimicrob. Agents Chemother. |
pmid:26883709
|
Mukai S et al. |
Macrolides sensitize EGFR-TKI-induced non-apoptotic cell death via blocking autophagy flux in pancreatic cancer cell lines. |
2016 |
Int. J. Oncol. |
pmid:26718641
|
Hassan ST et al. |
In vitro synergistic effect of Hibiscus sabdariffa aqueous extract in combination with standard antibiotics against Helicobacter pylori clinical isolates. |
2016 |
Pharm Biol |
pmid:26731378
|
Çağan-Appak Y et al. |
Clarithromycin resistance and 23S rRNA gene point mutations of Helicobacter pylori infection in children. |
2016 |
Turk. J. Pediatr. |
pmid:28276208
|
Oh B et al. |
The Effect of Probiotics on Gut Microbiota during the Helicobacter pylori Eradication: Randomized Controlled Trial. |
2016 |
Helicobacter |
pmid:26395781
|